Stockreport

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting [Yahoo! Finance]

Zentalis Pharmaceuticals, Inc. - common stock  (ZNTL) 
PDF a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that an abstract has been accepted [Read more]